Urology News and Research

Latest Urology News and Research

Wake Forest, UCSD develop new genetic test for prostate cancer

Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic test to predict a man's risk for prostate cancer. Use of the test could reduce the need for repeat biopsies in men who have had a negative biopsy.

18 Jul 2012

U.S. News & World Report names Methodist among 2012 America's Best Hospitals

The Methodist Hospital ranked among the country's top hospitals in 13 specialties in U.S. News & World Report's 2012 America's "Best Hospitals"issue, and was named the No. 1 hospital in Texas.

18 Jul 2012

Weighing up the gains for smokers who quit

People seem to gain more weight after giving up smoking than has previously been estimated, report researchers.

17 Jul 2012

ERBA Diagnostics to showcase full range of products at AACC annual meeting

ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, is pleased to announce that Suresh Vazirani, Chairman of ERBA Diagnostics, will be a key note speaker at the International Marketing Brief (IMB) in conjunction with the AACC.

16 Jul 2012

FDA approves Watson's ANDA for Next Choice ONE DOSE emergency contraceptive

Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Next Choice ONE DOSE (Levonorgestrel Tablet, 1.5 mg), the generic equivalent to Teva Women's Health's Plan B One-Step. Watson plans to launch the product immediately.

13 Jul 2012

FDA approves Watson’s ANDA for generic ARTHROTEC

Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc - Florida has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium and Misoprostol Delayed-Release Tablets, the generic equivalent to G.D. Searle's ARTHROTEC.

12 Jul 2012

Symptom relief at the core of prostate patient management

More focus should be placed on relieving the most bothersome or “core” symptom for patients with benign prostatic hyperplasia, report Korean researchers.

11 Jul 2012

National quality performance standards for disposable adult absorbent products from NAFC

A council headed by the National Association For Continence (NAFC) released its recommended national quality performance standards for disposable adult absorbent products for incontinence in the frail, elderly and/or disabled populations.

11 Jul 2012

Abused children may become obese adults

Severity of abuse in childhood or adolescence is associated with an increased risk for overall and central obesity in adulthood, report researchers.

10 Jul 2012

Obese achieve functional improvements after trauma rehab

Obese patients participating in a rehabilitation program for orthopedic trauma can achieve meaningful functional independence before discharge, US research shows.

10 Jul 2012

Diabetes drug raises bladder cancer risk

Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.

10 Jul 2012

Urinary components can both boost and impair crystallization

The prevention of renal stone formation with crystallization inhibitors somewhat depends on the joint effect of such compounds in the urine matrix, rather than on the individual action of each inhibitor, report researchers.

10 Jul 2012

Steroid receptor gene variant impacts metabolic health

A variant in the glucocorticoid receptor gene may be associated with increased body fat and insulin resistance, show study findings.

10 Jul 2012

Researchers discover mechanism that favours disappearance and inhibition of SCC development

Skin squamous cell carcinoma (SCC) is a subtype of very aggressive skin cancers that usually develops in sunexposed body regions, but can also affect a large number of organs such as the bladder, esophagus, lungs etc. However, little is known about the biology of these cells, which consequently makes difficult the generation of new specific therapies; actually, the standard treatments are based on surgery and subsequent radiotherapy.

10 Jul 2012

Scientists develop novel anticancer drug designed to travel through the bloodstream

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins.

10 Jul 2012

Methylation provides signal of unique mix of leukocytes

When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers.

10 Jul 2012

Hormone therapy still an acceptable treatment for menopausal symptoms: New joint statement

After 10 years of debate regarding the risks and benefits of hormone therapy, 15 top medical organizations have come together to issue a statement of agreement regarding the benefits of hormone therapy for symptomatic menopausal women. It was July 9, 2002, when the controversial, highly publicized Women's Health Initiative (WHI) published its assessment of hormone therapy for the prevention of chronic disease and concluded that risks exceeded benefits.

10 Jul 2012